Clinical Resources A-Z

We have developed hundreds of resources to support healthcare professionals and their patients. All are free to download, print, and share in your practice. Each printable (PDF) resource includes in its footer the date it was last reviewed and a QR code that links to the current online version.

Using the Clinical Resources Library

How to Find Your Answer

  • By default, results are sorted alphabetically by title. You can also sort results by document number or by date (most recently updated first).
  • Some filter options may become disabled as you narrow your selections.
  • Filters are easily added and removed. Click or tap on the X to remove individual filters or choose “Reset All Filters” to remove all filters.
Results (6)

Standing Orders for Administering 2025-2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer Nuvaxovid (Sanofi-Novavax) COVID-19 vaccine to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3141
Updated on: 11/13/25
Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to children 6 months through 11 years, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, and IDSA are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140a
Updated on: 11/13/25
Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140
Updated on: 11/13/25
Language: English

Partner Resources

Alliance for Immunization in Michigan (AIM)

A resource for immunization management, patient education, and other quality resources.

California Department of Public Health

Centers for Disease Control & Prevention

Institute for Safe Medication Practices

Vaccine Adverse Event Reporting System (HHS)

This page was updated on .